Seroatlas · Human Serome Atlas

TMEM202

Transmembrane protein 202

Also known as: FLJ27523, TM202_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
A6NGA9
Gene
TMEM202
Ensembl
ENSG00000187806
Chromosome
15
Canonical length
273 aa
Protein class
Predicted intracellular proteins, Predicted membrane proteins, Transporters

OverviewNCBI Gene

Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

273 residues, UniProt reviewed canonical sequence.

>A6NGA9|TMEM202
     1  MERREHLTLT FHSPEVPKIK GNRKYQRPTV PAKKHPSASM SCQRQQQLMD QAHIYIRTLC
    61  GSLCSFSLLM LIAMSPLNWV QFLVIKNGLE LYAGLWTLCN HELCWSHTPK PPYYLQYSRA
   121  FFLISVFTIL TGLGWLFSSW ILNRGSMTTN LDLKVSMLSF ISATCLLLCL NLFVAQVHWH
   181  TRDAMESDLL WTYYLNWCSD IFYMFAGIIS LLNYLTSRSP ACDENVTVIP TERSRLGVGP
   241  VTTVSPAKDE GPRSEMESLS VREKNLPKSG LWW

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TMEM202 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.44
Highest tissue expression
12 nTPM

Expression across tissuesHPA

Tissue

  • testis: 12 nTPM
  • adipose tissue: 0 nTPM
  • adrenal gland: 0 nTPM
  • amygdala: 0 nTPM
  • appendix: 0 nTPM
  • basal ganglia: 0 nTPM

Single-cell type

  • late primary spermatocytes: 150 nCPM
  • late spermatids: 93 nCPM
  • early spermatids: 67 nCPM
  • early primary spermatocytes: 8.5 nCPM
  • differentiating spermatogonia: 1.4 nCPM
  • sertoli cells: 1.4 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebral cortex: 0.3 nTPM
  • basal ganglia: 0.2 nTPM
  • midbrain: 0.2 nTPM
  • cerebellum: 0.1 nTPM
  • hippocampal formation: 0.1 nTPM
  • medulla oblongata: 0.1 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.51
gnomAD pLI
0
gnomAD missense Z
0.23
DepMap mean gene effect
0.07
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TMEM202 as an antibody target. Whether an autoantibody or antibody against TMEM202 could matter depends on whether native TMEM202 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TMEM202 is annotated at the cell surface, where native TMEM202 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label TMEM202 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TMEM202. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...